Dr. Tomas Kahn informed curasan AG, subsequent to the resolution of the supervisory board on the full implementation of the capital increase, that he will resign from his office as member of the supervisory board of the Company at the end of 31 August 2019. In agreement with their major shareholders, the company will propose to the court in charge, in a timely manner, a suitable successor for court appointment as member of the supervisory board of curasan AG until the next General Meeting of the company.